Literature DB >> 25914455

Tools for primary care management of inflammatory bowel disease: do they exist?

Alice L Bennett1, Pia Munkholm1, Jane M Andrews1.   

Abstract

Healthcare systems throughout the world continue to face emerging challenges associated with chronic disease management. Due to the likely increase in chronic conditions in the future it is now vital that cooperation and support between specialists, generalists and primary health care physicians is conducted. Inflammatory bowel disease (IBD) is one such chronic disease. Despite specialist care being essential, much IBD care could and probably should be delivered in primary care with continued collaboration between all stakeholders. Whilst most primary care physicians only have few patients currently affected by IBD in their caseload, the proportion of patients with IBD-related healthcare issues cared for in the primary care setting appears to be widespread. Data suggests however, that primary care physician's IBD knowledge and comfort in management is suboptimal. Current treatment guidelines for IBD are helpful but they are not designed for the primary care setting. Few non-expert IBD management tools or guidelines exist compared with those used for other chronic diseases such as asthma and scant data have been published regarding the usefulness of such tools including IBD action plans and associated supportive literature. The purpose of this review is to investigate what non-specialist tools, action plans or guidelines for IBD are published in readily searchable medical literature and compare these to those which exist for other chronic conditions.

Entities:  

Keywords:  Crohn’s disease; Guidelines; Inflammatory bowel disease; Management tools; Ulcerative colitis

Mesh:

Year:  2015        PMID: 25914455      PMCID: PMC4402293          DOI: 10.3748/wjg.v21.i15.4457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  65 in total

1.  Guideline for the management of chronic asthma in children--2009 update.

Authors:  C Motala; R J Green; A I Manjra; P C Potter; H J Zar
Journal:  S Afr Med J       Date:  2009-12

Review 2.  Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Authors:  L Sutherland; J K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

3.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

4.  Shared care in gastroenterology: GPs' views of open access to out-patient follow-up for patients with inflammatory bowel disease.

Authors:  W Y Cheung; J Dove; B Lervy; I T Russell; J G Williams
Journal:  Fam Pract       Date:  2002-02       Impact factor: 2.267

5.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.

Authors:  Charles N Bernstein; Michael Fried; J H Krabshuis; Henry Cohen; R Eliakim; Suleiman Fedail; Richard Gearry; K L Goh; Saheed Hamid; Aamir Ghafor Khan; A W LeMair; Qin Ouyang; J F Rey; Ajit Sood; Flavio Steinwurz; Ole O Thomsen; Alan Thomson; Gillian Watermeyer
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

Review 6.  A critical review of self-management and educational interventions in inflammatory bowel disease.

Authors:  Cate Barlow; Debbie Cooke; Kathleen Mulligan; Eric Beck; Stanton Newman
Journal:  Gastroenterol Nurs       Date:  2010 Jan-Feb       Impact factor: 0.978

7.  Information needs and preferences in IBD (IBD self-management: the AGA guide to Crohn's disease and ulcerative colitis).

Authors:  Sunanda Kane
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

8.  Inflammatory bowel disease: epidemiology and management in an English general practice population.

Authors:  G P Rubin; A P Hungin; P J Kelly; J Ling
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

Review 9.  Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Authors:  Brian G Feagan; John K Macdonald
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 10.  [Guidelines for 'Asthma in children (ages 0-19)' for youth healthcare].

Authors:  Jacqueline M Breuning-Boers; Nen Heerdink; Mascha Kamphuis; Helma van Gameren-Oosterom; Caren Lanting
Journal:  Ned Tijdschr Geneeskd       Date:  2012
View more
  10 in total

1.  The financial impact of a nurse-led telemedicine service for inflammatory bowel disease in a large district general hospital.

Authors:  Seth Ian Squires; Allan John Boal; Graham Douglas Naismith
Journal:  Frontline Gastroenterol       Date:  2015-10-09

2.  Incidence and prevalence of inflammatory bowel disease in Devon, UK.

Authors:  Ben Hamilton; Harry Green; Neel Heerasing; Peter Hendy; Lucy Moore; Neil Chanchlani; Gareth Walker; Claire Bewshea; Nicholas A Kennedy; Tariq Ahmad; James Goodhand
Journal:  Frontline Gastroenterol       Date:  2020-06-24

Review 3.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10

4.  Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study.

Authors:  Sofía García-Sanjuán; Manuel Lillo-Crespo; Miguel Richart-Martínez; Ángela Sanjuán-Quiles
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

5.  Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease.

Authors:  Sharmila S Prasad; Simon Keely; Nicholas J Talley; Therése Kairuz; Marjorie M Walker
Journal:  Pharmacy (Basel)       Date:  2020-04-17

6.  Knowledge and attitudes of primary healthcare physicians toward the diagnosis and management of inflammatory bowel disease following an educational intervention: A comparative analysis.

Authors:  Rwan Alharbi; Faizah Almahmudi; Yahya Makhdoom; Mahmoud Mosli
Journal:  Saudi J Gastroenterol       Date:  2019 Sep-Oct       Impact factor: 2.485

7.  Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.

Authors:  Rogerio S Parra; Julio M F Chebli; Heda M B S Amarante; Cristina Flores; Jose M L Parente; Odery Ramos; Milene Fernandes; Jose J R Rocha; Marley R Feitosa; Omar Feres; Antonio S Scotton; Rodrigo B Nones; Murilo M Lima; Cyrla Zaltman; Carolina D Goncalves; Isabella M Guimaraes; Genoile O Santana; Ligia Y Sassaki; Rogerio S Hossne; Mauro Bafutto; Roberto L K Junior; Mikaell A G Faria; Sender J Miszputen; Tarcia N F Gomes; Wilson R Catapani; Anderson A Faria; Stella C S Souza; Rosana F Caratin; Juliana T Senra; Maria L A Ferrari
Journal:  World J Gastroenterol       Date:  2019-10-14       Impact factor: 5.742

8.  Extracts from Hericium erinaceus relieve inflammatory bowel disease by regulating immunity and gut microbiota.

Authors:  Chen Diling; Yang Xin; Zheng Chaoqun; Yang Jian; Tang Xiaocui; Chen Jun; Shuai Ou; Xie Yizhen
Journal:  Oncotarget       Date:  2017-09-06

9.  Patient-reported healthcare expectations in inflammatory bowel diseases.

Authors:  Valérie Pittet; Carla Vaucher; Florian Froehlich; Michel H Maillard; Pierre Michetti
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

10.  Roles of healthcare professionals in the management of chronic gastrointestinal diseases with a focus on primary care: A systematic review.

Authors:  Sharmila S Prasad; Michael Potter; Simon Keely; Nicholas J Talley; Marjorie M Walker; Therése Kairuz
Journal:  JGH Open       Date:  2019-08-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.